In addition, RelB in advanced ovarian cancers, supports tumor-initiating cells through the cancer stem-like associated enzyme aldehyde dehydrogenase (ALDH), and the loss of RelB leads to reversion of chemoresistance and inhibition of tumorigenesis in mouse xenograft models37. The gene discussed is RELB; the disease is cancer.